MedTrace Logo

Psychosocial Stress on QOL in Saudi Arabian Patients with Alopecia Areata

NCT06802705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 398

Last updated 2025-01-31

No results posted yet for this study

Summary

Background: Alopecia areata (AA) is an autoimmune disorder that causes non-scaring hair loss, and common psychiatric comorbidities such as depression and anxiety are often experienced among these patients. The underlying causes of this disorder, including environmental factors, immune responses, autoimmune reactions, and genetic predisposition, are still debated. This condition affects approximately 0.2% of the global population and has no specific gender preference, with an average onset age of 33 years. This study aims to assess the psychosocial impact on quality of life in individuals with alopecia areata in Saudi Arabia Methodology: This study employed a cross-sectional questionnaire survey among Alopecia areata patients, targeting both Saudi and non-Saudi participants of both genders, from October 2023 - March 2024. The sample size is determined to be 384 participants based on a confidence level of 95%. By investigating the psychological impact of AA in Saudi Arabia.

Conditions

Interventions

BEHAVIORAL

Psychosocial Stress on Quality of Life

Psychosocial Stress on Quality of Life in Saudi Arabian Patients with Alopecia Areata

Sponsors & Collaborators

  • University of Jeddah

    lead OTHER

Principal Investigators

  • Saud Aleissa · MD FAAD, Assistant Professor, King Abdulaziz University and University Hospital, Jeddah, Saudi Arabia.

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-06-01
Completion
2024-07-01

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06802705 on ClinicalTrials.gov